Dec 18, 2017 by Brian FeroldiThis News Caused TransEnterix's Stock to SpikeTraders cheer after the company announces that it has found a way to monetize its SurgiBot system.
Dec 15, 2017 by Brian Feroldi10 Highest-Yielding Dividend Stocks: Are Any Worth BuyingThese companies offer the fat payouts income investors love, but all too often, extra-high yields are a danger signal.
Dec 14, 2017 by Brian Feroldi3 Stocks That Cut You a Check Each MonthLooking for monthly income? These three stocks have you covered.
Dec 13, 2017 by Brian Feroldi, Travis Hoium, and Leo Sun3 Stocks Your Children Will Brag About SomedayLooking to build generational wealth? These three stocks can get the ball rolling.
Dec 12, 2017 by Brian FeroldiThis Is Why Global Blood Therapeutics Inc. Is Sinking TodayMixed clinical data from a case study involving a key compound causes traders to flee.
Dec 12, 2017 by Brian Feroldi, Jeremy Bowman, and Neha Chamaria3 Top Index Funds for Your PortfolioWant to invest without having to pick your own stocks? These three funds have you covered.
Dec 9, 2017 by Brian Feroldi, Travis Hoium, and Leo Sun3 Growth Stocks Worth Owning for the Next 50 YearsThese three stocks are tailor-made for buy-and-hold investors.
Dec 8, 2017 by Brian FeroldiHere's Why Radius Health Is Rising TodayTraders cheer after the company presents encouraging clinical data at a medical conference.
Dec 8, 2017 by Brian FeroldiDuluth Holdings Keeps Moving ForwardNew store openings and customer gains enabled management to reaffirm its guidance for the year.
Dec 7, 2017 by Brian FeroldiHere's Why Duluth Holdings Is Sinking TodayShares tumble after the company's third-quarter results come up short of expectations.
Dec 7, 2017 by Brian Feroldi, Jeremy Bowman, and Neha Chamaria3 High-Growth Stocks That Could SoarLooking for a few stocks that hold massive upside potential? These three have you covered.
Dec 6, 2017 by Brian FeroldiWhy Immunomedics, Inc. Is Soaring TodayThe release of upbeat clinical data from an important phase 2 trial causes traders to cheer.
Dec 5, 2017 by Brian FeroldiWhy Alexion Pharmacteuicals Sank 8.9% in NovemberA handful of positive updates still wasn't enough to reverse the negative sentiment.
Dec 5, 2017 by Brian FeroldiWhy Revance Therapeutics Is Soaring TodayUpbeat news from two phase 3 trials is met with investor enthusiasm.
Dec 5, 2017 by Brian FeroldiWhy MannKind Corporation Dipped 4.8% in NovemberDisappointing quarterly results and downbeat guidance caused traders to sell.
Dec 4, 2017 by Brian FeroldiWhy CVS Health Is Sinking TodayShares fall after the company announces the details of its mega-merger deal with Aetna.
Dec 4, 2017 by Brian Feroldi3 Reasons Why Aetna Isn't Up 14% TodayA CVS/Aetna mega-merger could be a game-changer for the American healthcare system. Too bad Wall Street doesn't think that it is going to happen.
Dec 4, 2017 by Brian FeroldiWhere Will Exact Sciences Corporation Be in 5 Years?Investors in the cancer detection company have enjoyed a phenomenal run recently, but where is this business heading in the next half-decade?
